MAPK1 and cancer: In common with the cytoplasmic ERK-specific phosphatase DUSP6/MKP-3 (see Section 3.1.3), elevated DUSP5 expression is observed in a range of Ras or Braf mutant cancer cells [[123], [124], [125]] where it is presumed to suppress oncogenic ERK activation.